Feedback
Insulin, 180 Minutes
2013566
Ordering Recommendation
Mnemonic
INSULIN180
Methodology
Quantitative Chemiluminescent Immunoassay
Performed
Sun-Sat
Reported
Within 24 hours
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Serum Separator Tube (SST). Also acceptable: Lavender (EDTA) or Pink (K2EDTA). 
Specimen Preparation
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transport 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.4 mL) 
Storage/Transport Temperature
Frozen. 
Unacceptable Conditions
Heparinized plasma, I.V. fluid, or Vitreous fluid. Gray (sodium fluoride/potassium oxalate). Hemolyzed specimens. 
Remarks
 
Stability
After separation from cells: Ambient: 8 hours; Refrigerated: 1 week; Frozen: 1 month 
Reference Interval
180 minutes: 4-62 µIU/mL
Interpretive Data
This test reacts on a nearly equimolar basis with the analogs insulin aspart, insulin glargine, and insulin lispro. Insulin detemir exhibits approximately 50 percent cross-reactivity. Test reactivity with insulin glulisine is negligible (<3 percent). To convert to pmol/L, multiply by 6.0. The reference interval is based on a 75 g glucose challenge.

Components
Component Test Code*Component Chart NameLOINC
2013567Insulin, 180 Minutes27828-3
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases